Table 5.

Quality of imputation or genotyping of SNPs presented in Table 2^a

			arcOGEN		WTCCC2		Anti‐CCP–negative RA cases
Chr.	SNP ID	Gene	INFOb	Type	INFOb	Type	Genotyping rate, %c
1	rs10489912	NFIA	1.00	Directly typed	1.00	Directly typed	99.8
1	rs2249707	SLAMF9	1.00	Directly typed	1.00	Directly typed	99.9
2	rs10181656	STAT4	0.99	Imputed	1.00	Imputed	100
2	rs888427	CYBRD1	1.00	Directly typed	1.00	Directly typed	99.9
4	rs6533712	CAMK2D	0.99	Imputed	1.00	Directly typed	100
5	rs71624119	ANKRD55	0.98	Imputed	0.97	Imputed	100
5	rs528092	C5orf30	1.00	Imputed	1.00	Imputed	100
6	rs10440835	PRL	0.99	Imputed	1.00	Directly typed	99.9
8	rs4840565	BLK	0.99	Imputed	1.00	Imputed	100
11	rs613587	FLI1	1.00	Directly typed	1.00	Directly typed	100
16	rs28698667	IL27	1.00	Directly typed	1.00	Imputed	99.8
17	rs2689	HNF1B	0.99	Imputed	1.00	Imputed	100
18	rs16955629	RAB31	1.00	Directly typed	1.00	Directly typed	100
21	rs9979383	RUNX1	1.00	Directly typed	1.00	Directly typed	99.9

^aSNPs = single‐nucleotide polymorphisms; Chr. = chromosome; WTCCC2 = Wellcome Trust Case Control Consortium 2.

^bPostimputation INFO score.

^cNumber of anti–citrullinated protein (anti‐CCP)–negative rheumatoid arthritis (RA) patients in the replication data set (UK) with available genotype information after quality control, divided by the total number of individuals (n = 1,024).